Skip to main content

Pharmacotherapy in Older People

Training course of the ESC Working Group on Cardiovascular Pharmacotherapy, 16 May 2019

Summary

The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to present an engaging and interactive course to improve the professional knowledge and skills for cardiovascular pharmacotherapy in older patients.

The course will be held on 16 May in Vienna, one day prior to EuroCVP 2019, the annual meeting of the Working Group.

 

Introduction

In Europe and the Western World in particular, the proportion of older persons is dramatically increasing, which is predicted to add tremendous extra pressure to the strained health care systems.

Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid lowering drugs and glucose lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.

Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on services and patient outcomes. 

Scientific Programme

Click here to download the program as pdf

THURSDAY 16 May 2019

 

Cardiovascular Pharmacotherapy in Older People

An educational project by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

08:30 – 09:00       Registration

09:00 – 09:10       Welcome, introduction and course objectives, Thomas A. Schmidt, Keld Kjeldsen, Heinz Drexel

09:10 – 10:00       Session 1: General Aspects

  

09:10 - 09:25

Demographical developments, and feasibility of treating older patients in a short stay unit, the “Elder” trial
Thomas Andersen Schmidt

09:25 - 09:30

Discussion

09:30 - 09:55

Drug metabolism in older people

Juan Tamargo

09:55 - 10:00

Discussion

10:00 – 10:30       Session 2: Diuretics

  

10:00 - 10:25

Diuretics and salts in older patients
Keld Kjeldsen

10:25 - 10:30

Discussion

10:30 – 10:45       Coffee break, Networking, Poster Viewing

10:45 – 11:15       Session 3: Antihypertensives

  

10:45 - 11:10

Benefit versus drawback of blood pressure treatment in older patients

Claudio Borghi

11:10 - 11:15

Discussion

11:15 – 12:00       Session 4: NOACs

  

11:15 - 11:25

Benefit versus drawback of NOAC treatment in older patients

Alexander Niessner

11:25 - 11:30

Discussion

11:30 - 12:00

Workshop including case stories

Heinz Drexel & Keld Kjeldsen & Thomas Andersen Schmidt

12:00 – 13:00       Lunch break, Networking

13:00 – 13:30       Session 5: Antiarrhythmics

  

13:00 - 13:25

Atrial fibrillation and case story

Kurt Huber

13:25 - 13:30

Discussion

13:30 – 14:00       Session 6: Lipid lowering drugs

  

13:30 - 13:55

Lipidology and case story

Heinz Drexel

13:55 - 14:00

Discussion

14:00 – 14:30       Coffee break, Networking, Poster Viewing

14:30 – 15:00       Session 7: Glucose lowering drugs

  

14:30 - 14:55

Tight glycemic control, pro et con

Heinz Drexel (pro); Thomas Andersen Schmidt (con)

14:55 - 15:00

Discussion

15:00 – 16:30       Session 8: Polypharmacy

  

15:00 - 15:15

Polypharmacy in older people

Juan Tamargo

15:15 - 15:20

Discussion

15:20 - 15:55

Workshop including case stories

Heinz Drexel & Keld Kjeldsen & Thomas Andersen Schmidt

15:55 - 16:00

Discussion

16:00                     Coffee, Networking

Registration

CategoryFee

Full delegate fee

Register

 €                       300,00

Members Fee (working group members) *

Register

 €                       100,00

Reduced fee (Working group members under 40 years old)

Register

 €                         50,00

* Click here to become a member for FREE and save € 200 on registration fees

 

Course directors

Thomas A Schmidt, MD, DSc, FESC

Keld Kjeldsen, MD, DSc

Heinz Drexel, MD, DSc, FESC